It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Originally posted by ReelView
Homosexuals are involved in degenerate activity. That activity means the energy of their blood and it's vitality is perverse. Subtle as that may be, blood transfusions are yet another scam to degrade humans. Homosexuals are among the most degraded. Their blood is even worse for others to consume.
Originally posted by ReelView
Homosexuals are involved in degenerate activity. That activity means the energy of their blood and it's vitality is perverse. Subtle as that may be, blood transfusions are yet another scam to degrade humans. Homosexuals are among the most degraded. Their blood is even worse for others to consume.
Originally posted by halfoldman
reply to post by MotherofBlessings
Thanks for bringing up tattoos, and some others have mentioned this also.
I was wondering about this, and I thought of Pamela Anderson who got Hepatitis C that way.
So I suppose this debate goes beyond HIV and homophobia, although I still have virtually no info on the tests used, whether people are paid to give blood and so forth, because it all varies from country to country.
Are the latest, most expensive tests used?
How dated is our information, and where can we get the latest?
Do some countries have a a state-run blood bank, or are they private companies? If so, how much leeway do they have with the tests they use?
(We've heard about many exclusionary criteria, but nothing on the tests themselves, like the 12-day or fortnight tests?)
In order to narrow the infectious period (window) between the time of viral exposure and the time a virus can be serologically detected, blood centers throughout the United States are implementing nucleic acid testing (NAT) for HIV and HCV. Early studies have shown that NAT testing can significantly narrow the infectious window, particularly for HCV. There is the potential that NAT testing could completely eradicate the transfusion risk of HIV and HCV. The test is thus likely to add substantially to the safety of blood transfusions and, although not licensed, has been implemented by all blood suppliers and transfusion services in the United States. NAT testing is currently being used under an IND mechanism.
Blood donations are tested for the following:
* ABO and Rh blood types.
* Unexpected red blood cell antibodies that are a result of prior transfusion, pregnancy, or other factors.
* Hepatitis B surface antigen, indicating a current infection (hepatitis) or carrier state for hepatitis B virus.
* Antibody to hepatitis B core antigen, indicator of a present or past infection with the hepatitis B virus.
* Antibody to hepatitis C virus, indicating a current or past infection with hepatitis C virus (most common cause of non-A/non-B hepatitis).
* Antibody to HTLV-I/II, indicator of infection with a virus that may cause adult T-cell leukemia or neurological disease.
* Antibody to HIV-1/2, indicator of infection with human immunodeficiency virus (HIV).
* Nucleic Acid Test (NAT) for hepatitis C (HCV), hepatitis B (HBV) and HIV.
* Screening test for antibodies to syphilis.
* NAT for West Nile Virus (WNV).
* Enzyme-linked immunoassay (ELISA) test for Trypanosoma cruzi (Chagas Disease).
In addition, all platelet apheresis donations are tested for bacterial contamination.
What tests are performed on donated blood?
After blood has been drawn, it is tested for ABO group (blood type) and Rh type (positive or negative), as well as for any unexpected red blood cell antibodies that may cause problems in a recipient. Screening tests also are performed for evidence of donor infection with hepatitis B and C viruses, human immunodeficiency viruses HIV-1 and HIV-2, human T-lymphotropic viruses HTLV-I and HTLV-II, and syphilis. While not required, blood donors are also being tested for West Nile virus. The FDA also has licensed one test for the screening of blood for Chagas' disease, but has not required that all blood products be screened.
The specific tests currently performed are listed below:
* Hepatitis B surface antigen (HBsAg)
* Hepatitis B core antibody (anti-HBc)
* Hepatitis C virus antibody (anti-HCV)
* HIV-1 and HIV-2 antibody (anti-HIV-1 and anti-HIV-2)
* HTLV-I and HTLV-II antibody (anti-HTLV-I and anti-HTLV-II)
* Serologic test for syphilis
* Nucleic acid amplification testing (NAT) for HIV-1 and HCV
* NAT for West Nile virus (WNV) (this test is not required by the Food and Drug Administration [FDA], the organization responsible for federally regulating the blood supply)
* Antibody test for Trypanosoma cruzi, the agent of Chagas' disease (this test is also not required by FDA)
The last review that was taken into the Blood Service policy determined, based on statistical and epidemiological analysis of risk, that if the ban on MSM donating blood were lifted the risk of HIV entering the blood stocks would rise by 500%. They also found that if the ban was changed to only exclude men who have had sex with another man in the previous 12 months the increase would still be around 60%.